Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanislas Chaussade

Showing results (1-10 of 247) with videos related to

Pageof 25
Sort By:
Presse Medicale (Paris, France : 1983)|April 5, 2011
[Barrett's Esophagus: Today's knowledge]Stanislas Chaussade
Presse Medicale (Paris, France : 1983)|July 15, 2003
[Collagenous colitis complicated by multiple ulcerations]Gilles Roseau, Stanislas Chaussade
Presse Medicale (Paris, France : 1983)|February 7, 2004
[Role of Helicobacter pylori in drug-induced gastrointestinal bleeding]Stanislas Chaussade, Vered Abitbol
Presse Medicale (Paris, France : 1983)|February 7, 2004
[Are dyspepsia or gastroesophageal reflux predictive of serious digestive events during treatment with NSAIDs? How should they be treated?]Vered Abitbol, Stanislas Chaussade
Lancet (London, England)|October 7, 2004
Calcium supplementation for preventing colorectal cancer: where do we stand?Robert Benamouzig, Stanislas Chaussade
Therapie|June 22, 2007
[Pro or con the phenotyping/genotyping of patients treated by 5-Fluorouracil to prevent adverse drug reactions?]Romain Coriat, Stanislas Chaussade
Endoscopy International Open|May 2, 2020
COVID-19: How to select patients for endoscopy and how to reschedule the procedures?Thierry Ponchon, Stanislas Chaussade
Presse Medicale (Paris, France : 1983)|February 7, 2004
[NSAIDs digestive risk: epidemiologic data]Philippe Ravaud, Stanislas Chaussade
La Revue Du Praticien|March 17, 2004
[Chemopreventive agents in colorectal cancer]Robert Benamouzig, Stanislas Chaussade
Presse Medicale (Paris, France : 1983)|February 7, 2004
[Risk factors for upper digestive tract toxicity with NSAIDs (excluding Helicobacter pylori)]Dominique Lamarque, Stanislas Chaussade
Pageof 25

Showing results (1-10 of 247) with videos related to

Sort By:
Pageof 25
Presse Medicale (Paris, France : 1983)|April 5, 2011
[Barrett's Esophagus: Today's knowledge]Stanislas Chaussade
Presse Medicale (Paris, France : 1983)|July 15, 2003
[Collagenous colitis complicated by multiple ulcerations]Gilles Roseau, Stanislas Chaussade
Presse Medicale (Paris, France : 1983)|February 7, 2004
[Role of Helicobacter pylori in drug-induced gastrointestinal bleeding]Stanislas Chaussade, Vered Abitbol
Presse Medicale (Paris, France : 1983)|February 7, 2004
[Are dyspepsia or gastroesophageal reflux predictive of serious digestive events during treatment with NSAIDs? How should they be treated?]Vered Abitbol, Stanislas Chaussade
Lancet (London, England)|October 7, 2004
Calcium supplementation for preventing colorectal cancer: where do we stand?Robert Benamouzig, Stanislas Chaussade
Therapie|June 22, 2007
[Pro or con the phenotyping/genotyping of patients treated by 5-Fluorouracil to prevent adverse drug reactions?]Romain Coriat, Stanislas Chaussade
Endoscopy International Open|May 2, 2020
COVID-19: How to select patients for endoscopy and how to reschedule the procedures?Thierry Ponchon, Stanislas Chaussade
Presse Medicale (Paris, France : 1983)|February 7, 2004
[NSAIDs digestive risk: epidemiologic data]Philippe Ravaud, Stanislas Chaussade
La Revue Du Praticien|March 17, 2004
[Chemopreventive agents in colorectal cancer]Robert Benamouzig, Stanislas Chaussade
Presse Medicale (Paris, France : 1983)|February 7, 2004
[Risk factors for upper digestive tract toxicity with NSAIDs (excluding Helicobacter pylori)]Dominique Lamarque, Stanislas Chaussade
Pageof 25